SNDX Operating Cash Flow (Statement)
Syndax Pharmaceuticals Inc · Operating Cash Flow (Statement)
SNDX Operating Cash Flow (Statement)
Latest reported-$220.64Mperiod ending
SNDX Cash from Operations (-$10.02M → -$220.64M)
Annual operating cash flow (statement)
High-resolution chart · PNG
SNDX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -322,980,000 | |
| -274,903,000 | |
| -160,601,000 | |
| -133,675,000 | |
| 29,131,000 | |
| -71,260,000 | |
| -50,612,000 | |
| -68,531,000 | |
| -47,371,000 | |
| -35,157,000 | |
| -2,428,000 | |
| -14,393,000 | |
| -7,295,000 | |
| -9,284,000 | |
| -10,022,000 |